Cardiovascular Health

Physicans’ Health Study: Healthy Lifestyle Obviates Risk of Heart Failure

By Staff Writer - Vol. 11, No. 2. Summer, 2010

Statistically, the prevalence of heart failure increases with age, but a new prospective study is validating what holistic physicians have known for years: that a healthy lifestyle can markedly reduce the risk.

Vitamin E Tocotrienols Prevent Post-Stroke Neuronal Death

By Howard Simon | Contributing Writer - Vol. 11, No. 1. Spring, 2010

A new study

shows that tocotrienols, an important component of naturally occurring Vitamin E, can prevent neural damage following ischemic stroke, potentially improving post-stroke outcomes.

Beyond NTDs, Folic Acid May Also Prevent Congenital Heart Problems

By Tori Hudson, ND | Contributing Writer - Vol. 10, No. 4. Winter, 2009

Folic acid supplementation before and during pregnancy is widely recommended for preventing neural tube defects. New data indicate that it can also reduce the risk of cleft lip and congenital heart defects. At the other end of the age spectrum, folic acid in combination with vitamins B6 and B12 can reduce a woman’s risk of age-related macular degeneration.

Ubiquinol, the “Other CoQ10” May Help When Standard Forms Don’t

By Dallas Clouatre, PhD | Contributing Writer - Vol. 10, No. 4. Winter, 2009

Clinical research on CoQ10 continues to point toward new uses including blood pressure reduction, glycemic control and potentially reducing risk of neurodegenration. CoQ10 in its reduced form, known as ubiquinol, often improves outcomes in conditions like as severe heart failure, when the more common ubiquinone form, has proven ineffective.

Hibiscus Hems Hypertension

By Tori Hudson, ND | Contributing Writer - Vol. 10, No. 4. Winter, 2009

Hibiscus, a popular tea herb in many parts of the world, can markedly lower systolic blood pressure in type II diabetic people with mild hypertension, according to a recent clinical trial. On the other hand, black tea tends to increase systolic pressure.

NIH-Sponsored Chelation Trial Seeks Study Sites for Heart Disease Patients

By Staff Writer - Vol. 9, No. 1. Spring, 2008

Chelation therapy to prevent heart attacks has never been accepted by mainstream cardiologists, but it is popular none the less, and increasingly so in the wake of trials questioning the value of drug-eluting stents. The Trial to Assess Chelation Therapy (TACT), a $30 million NIH-sponsored study, will hopefully provide definitive answers on whether chelation has a rightful place in heart disease prevention.

"Top Ten" Natural Approaches for Managing Coronary Artery Disease

By Erik L. Goldman | Editor in Chief

PHILADELPHIA—Holistic medicine is often considered more preventive than therapeutic, especially when it comes to cardiovascular disease. But even patients with advanced heart disease can benefit greatly from multimodal natural therapeutics.

Extended-Release Niacin Boosts Lipid-Lowering Power of Statin

By Erik L. Goldman | Editor in Chief - Vol. 3, No. 2. June, 2002

Niacin is every effective in reducing LDL and elevating HDL or "good" cholesterol. But it is under-used in part because many people taking standard forms of niacin experience intense flushing. Extended release forms of niacin are now available that eliminate this problem. A statin-niacin combination called Advicor is "the ideal drug combination" for reducing heart disease risk, says cardiologist William Insull, MD.

CV Risk Reduction Requires Much More than Statins

By Erik L. Goldman | Editor in Chief

ANAHEIM, CA—Statins will only go so far in reducing the incidence of cardiovascular events, said H. Robert Superko, MD, at Nutracon, an annual conference on advances in nutraceutical product development.

Helping Patients Take the Path Out of Cardiovascular Pathology

By Erik L. Goldman | Editor in Chief - Vol. 4, No. 2. April, 2003

SALT LAKE CITY—When talking to your patients about heart disease, offer them the choice between a Path or a Pathology, and help them identify their own obstacles to a healthier lifestyle, said S. A. Decker Weiss, NMD, at the annual meeting of the American Association of Naturopathic Physicians.